Exploring how p53's tetrameric structure binds DNA to regulate genes critical for cancer prevention, with recent structural breakthroughs and therapeutic implications.
Breakthrough in cancer treatment: A new biocompatible COF-MCM nanoporous hybrid drug delivery system for pH-controlled delivery of curcumin.
Exploring CARM1 as a prime target for next-generation cancer drugs through epigenetic modifications and small-molecule inhibitors.
Explore how curcumin from turmeric modulates microRNAs to combat diseases like cancer, Alzheimer's, and heart disease through modern scientific research.
Exploring the anticancer properties of Withaferin A, a potent compound from Ashwagandha, and its multi-targeted approach against cancer cells.
Exploring the profound dialogue between emotional states and cellular behavior in cancer through psychophysiological complementarity.
Exploring the complex relationship between psychological factors and cancer through cutting-edge psychosomatic oncology research.
Discover how macrocyclization enables polypharmacology in cancer treatment, creating multi-target drugs that overcome resistance by simultaneously inhibiting PI3K, mTOR, and PIM pathways.
Exploring how ATPase enzymes are hijacked by cancer cells to fuel metastasis, manipulate pH, and develop drug resistance, with insights into therapeutic strategies.
Exploring the role of apoptosis-related proteins caspase-6, caspase-9, FLIP and BNIP3 in esophageal squamous cell carcinomas and their therapeutic implications.